Your browser doesn't support javascript.
Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.
Park, Ae Kyung; Kim, Il-Hwan; Kim, Junyoung; Kim, Jeong-Min; Kim, Heui Man; Lee, Chae Young; Han, Myung-Guk; Rhie, Gi-Eun; Kwon, Donghyok; Nam, Jeong-Gu; Park, Young-Joon; Gwack, Jin; Lee, Nam-Joo; Woo, SangHee; No, Jin Sun; Lee, Jaehee; Ha, Jeemin; Rhee, JeeEun; Yoo, Cheon-Kwon; Kim, Eun-Jin.
  • Park AK; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim IH; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim J; Division of Bacterial Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim JM; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim HM; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee CY; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Han MG; Division of Viral Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Rhie GE; Division of High-Risk Pathogens, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kwon D; Division of Public Health Emergency Response Research, Bureau of Public Health Emergency Preparedness, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Nam JG; Division of Laboratory Diagnosis Analysis, Capital Regional Center for Disease Control and Prevention, Seoul, Korea.
  • Park YJ; Central Disease Control Headquarters Epidemiological Investigation Team, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Gwack J; Central Disease Control Headquarters Epidemiological Investigation Team, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee NJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Woo S; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • No JS; Division of High-Risk Pathogens, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee J; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Ha J; Division of Laboratory Diagnosis Analysis, Chungcheong Regional Center for Disease Control and Prevention, Daejeon, Korea.
  • Rhee J; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Yoo CK; Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim EJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Osong Public Health Res Perspect ; 12(1): 37-43, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-1117419
ABSTRACT
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Topics: Variants Language: English Journal: Osong Public Health Res Perspect Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Topics: Variants Language: English Journal: Osong Public Health Res Perspect Year: 2021 Document Type: Article